Salmeterol xinafoate STD-4-(1-hydroxy-2-((6-(4-phenylbutoxy)hexyl)amino)ethyl)-2-(hydroxymethyl)phenol 1-hydroxy-2-naphthoate; 2-Naphthalenecarboxylic acid, 1-hydroxy-, compd. with 4-hydroxy-α1-[[[6-(4-phenylbutoxy)hexyl]amino]methyl]-1,3-benzenedimethanol (1:1); (±)-4-Hydroxy-α 1-[[[6-(4-phenylbutoxy)hexyl]amino]methyl]-m-xylene-α,α ¢-diol 1-hydroxy-2-naphthoate (salt); 1,3-Benzenedimethanol, 4-hydroxy-α 1-[[[6-(4-phenylbutoxy)hexyl]amino]methyl]-, (±)-, 1-hydroxy-2-naphthalenecarboxylate: Salmeterol xinafoate-IMP-E-1-[4-Hydroxy-3-(hydroxymethyl)phenyl]-2-[[6-(1-methyl-3-phenylpropoxy) hexyl] amino]ethanol: Salmeterol xinafoate-IMP-G-1-[4-Hydroxy-3-[[[2-hydroxy-2-[4-hydroxy-3-(hydroxymethyl)phenyl]ethyl][6-(4-phenylbutoxy)hexyl]amino]methyl]phenyl]-2-[[6-(4-phenylbutoxy)hexyl]amino]ethanol
Xinafoic Acid-1-hydroxynaphthalene-2-carboxylic acid